Lantheus to Present at the Jefferies London Healthcare Conference
Lantheus to Present at the Jefferies London Healthcare Conference
BEDFORD, Mass., Nov. 13, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. ("Lantheus") (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced Bob Marshall, Chief Financial Officer and Treasurer, will present at the Jefferies London Healthcare Conference at 1:00 p.m. GMT (8 a.m. EST) on Wednesday, November 20.
馬薩諸塞州貝德福，2024年11月13日（環球新聞社）-- lantheus控股公司（"lantheus"）（納斯達克：LNTH）, 該公司是領先的放射性藥物公司，致力於幫助臨床醫生找到、戰勝和隨訪疾病，以提供更好的患者結局。今日宣佈，首席財務官兼主管Bob Marshall將於11月20日（星期三）下午1:00（GMT），美東時間上午8:00，在傑富瑞倫敦醫療保健大會上發表演講。
To access a live webcast of the presentation, please visit the Investors section of the Company's website at . A replay of the webcast will be available on the Company's website for at least 30 days following the live presentation.
要獲取演示文稿的實況網絡廣播，請訪問公司網站的投資人部分。從演示文稿實況之後的至少30天內，公司網站上將提供網絡廣播的重播。
About Lantheus
Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit .
關於lantheus
Lantheus是領先的放射性製藥公司，提供可以幫助臨床醫生找到、打擊和跟蹤疾病，從而提供更好的患者結果的重要科學。總部位於馬薩諸塞州，在加拿大和瑞典設有辦事處，Lantheus已提供放射性藥物解決方案超過65年。有關更多信息，請訪問該公司網站。
Contacts:
Mark Kinarney
Vice President, Investor Relations
978-671-8842
ir@lantheus.com
聯繫人：
馬克·基納尼
投資者關係副總裁
978-671-8842
ir@lantheus.com
Melissa Downs
Senior Director, External Communications
646-975-2533
media@lantheus.com
梅麗莎·唐斯
通信公關高級董事
646-975-2533
media@lantheus.com
Source: Lantheus Holdings, Inc.
來源: lantheus控股有限公司。
譯文內容由第三人軟體翻譯。
